These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 18824884)

  • 1. Is it possible to reduce the use of antibiotics in severe exacerbations of chronic obstructive pulmonary disease?
    Miravitlles M
    Respiration; 2008; 76(3):249-50. PubMed ID: 18824884
    [No Abstract]   [Full Text] [Related]  

  • 2. Factors predicting bacterial involvement in severe acute exacerbations of chronic obstructive pulmonary disease.
    Nseir S; Cavestri B; Di Pompeo C; Diarra M; Brisson H; Lemyze M; Roussel-Delvallez M; Durocher A
    Respiration; 2008; 76(3):253-60. PubMed ID: 18547944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skin reactivity to autologous bacteria isolated from respiratory tract of patients with obstructive pulmonary disease.
    Halasa J; Halasa M
    J Investig Allergol Clin Immunol; 2004; 14(2):149-53. PubMed ID: 15301305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Procalcitonin-guided antibiotic therapy in COPD exacerbations: closer but not quite there.
    Martinez FJ; Curtis JL
    Chest; 2007 Jan; 131(1):1-2. PubMed ID: 17218546
    [No Abstract]   [Full Text] [Related]  

  • 5. Procalcitonin levels in acute exacerbation of COPD admitted in ICU: a prospective cohort study.
    Daubin C; Parienti JJ; Vabret A; Ramakers M; Fradin S; Terzi N; Freymuth F; Charbonneau P; du Cheyron D
    BMC Infect Dis; 2008 Oct; 8():145. PubMed ID: 18947382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Systemic markers of exacerbated chronic obstructive pulmonary disease: how they can help with the decision of whether or not to prescribe antibiotics].
    Soler N
    Arch Bronconeumol; 2008 Nov; 44(11):581-3. PubMed ID: 19007562
    [No Abstract]   [Full Text] [Related]  

  • 7. [Comparative evaluation of probiotic activity in respect to in vitro pneumotropic bacteria and pharmacodynamics of biosporin-strain producers in patients with chronic obstructive pulmonary diseases].
    Bilev AE
    Voen Med Zh; 2002 Sep; 323(9):54-7. PubMed ID: 12449758
    [No Abstract]   [Full Text] [Related]  

  • 8. The role of bacteria in airway inflammation in exacerbations of chronic obstructive pulmonary disease.
    Murphy TF
    Curr Opin Infect Dis; 2006 Jun; 19(3):225-30. PubMed ID: 16645482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibiotic treatment of exacerbations of COPD: a randomized, controlled trial comparing procalcitonin-guidance with standard therapy.
    Stolz D; Christ-Crain M; Bingisser R; Leuppi J; Miedinger D; Müller C; Huber P; Müller B; Tamm M
    Chest; 2007 Jan; 131(1):9-19. PubMed ID: 17218551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The benefits of long-term systemic antimicrobial therapy in chronic obstructive pulmonary disease.
    Berim I; Sethi S
    Ther Adv Respir Dis; 2011 Jun; 5(3):207-16. PubMed ID: 21378062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Empiric antibiotics pending bronchoalveolar lavage data in patients without pneumonia significantly alters the flora, but not the resistance profile, if a subsequent pneumonia develops.
    Thakkar RK; Monaghan SF; Adams CA; Stephen A; Connolly MD; Gregg S; Cioffi WG; Heffernan DS
    J Surg Res; 2013 May; 181(2):323-8. PubMed ID: 22906560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial.
    Christ-Crain M; Jaccard-Stolz D; Bingisser R; Gencay MM; Huber PR; Tamm M; Müller B
    Lancet; 2004 Feb; 363(9409):600-7. PubMed ID: 14987884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotic therapy for exacerbations of chronic obstructive pulmonary disease (COPD).
    Butorac-Petanjek B; Parnham MJ; Popovic-Grle S
    J Chemother; 2010 Oct; 22(5):291-7. PubMed ID: 21123150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical predictors of bacterial involvement in exacerbations of chronic obstructive pulmonary disease.
    van der Valk P; Monninkhof E; van der Palen J; Zielhuis G; van Herwaarden C; Hendrix R
    Clin Infect Dis; 2004 Oct; 39(7):980-6. PubMed ID: 15472849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Third consensus document on the use of antimicrobial agents in chronic obstructive pulmonary disease exacerbations].
    ; ; ; ; ;
    Rev Esp Quimioter; 2007 Mar; 20(1):93-105. PubMed ID: 17530040
    [No Abstract]   [Full Text] [Related]  

  • 16. [Use of antibiotics in the exacerbation of chronic obstructive pulmonary disease].
    Alvarez F; Bouza E; García-Rodríguez JA; Mayer MA; Mensa J; Monsó E; Nodar E; Picazo JJ; Sobradillo V; Torres A
    Rev Esp Quimioter; 2001 Mar; 14(1):87-96. PubMed ID: 11376355
    [No Abstract]   [Full Text] [Related]  

  • 17. Procalcitonin in bronchoalveolar lavage fluid after severe pulmonary contusion.
    Hanes SD; Boucher BA
    Crit Care Med; 2002 Sep; 30(9):2171-2. PubMed ID: 12352076
    [No Abstract]   [Full Text] [Related]  

  • 18. Chronic obstructive pulmonary disease, antibiotics, and prediction of bacterial infection.
    De Maria A
    Clin Infect Dis; 2005 Mar; 40(5):769; author reply 769-70. PubMed ID: 15714431
    [No Abstract]   [Full Text] [Related]  

  • 19. [Role of antibiotherapy in acute exacerbation of chronic obstructive pulmonary disease].
    Cavassini M; Calandra T; Bridevaux PO
    Rev Med Suisse; 2007 Apr; 3(106):939-42. PubMed ID: 17575969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bronchoscopic validation of the significance of sputum purulence in severe exacerbations of chronic obstructive pulmonary disease.
    Soler N; Agustí C; Angrill J; Puig De la Bellacasa J; Torres A
    Thorax; 2007 Jan; 62(1):29-35. PubMed ID: 16928715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.